Cancer research in need of a scientific revolution: Using ‘paradigm shift’ as a method of investigation

Abstract

Despite important human and financial resources and considerable accumulation of scientific publications, patents, and clinical trials, cancer research has been slow in achieving a therapeutic revolution similar to the one that occurred in the last century for infectious diseases. It has been proposed that science proceeds not only by accumulating data but also through paradigm shifts. Here, we propose to use the concept of 'paradigm shift' as a method of investigation when dominant paradigms fail to achieve their promises. The first step in using the 'paradigm shift' method in cancer research requires identifying its founding paradigms. In this review, two of these founding paradigms will be discussed: (i) the reification of cancer as a tumour mass and (ii) the translation of the concepts issued from infectious disease in cancer research. We show how these founding paradigms can generate biases that lead to over-diagnosis and over-treatment and also hamper the development of curative cancer therapies. We apply the 'paradigm shift' method to produce perspective reversals consistent with current experimental evidence. The 'paradigm shift' method enlightens the existence of a tumour physiologic-prophylactic-pathologic continuum. It integrates the target/antitarget concept and that cancer is also an extracellular disease. The 'paradigm shift' method has immediate implications for cancer prevention and therapy. It could be a general method of investigation for other diseases awaiting therapy.

A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept

“…Approaching cancer as a foreign organism implies that the main tumor and any tumor cells must be destroyed to cure the patient, similar to treatments aimed at killing bacteria, viruses, and parasites. This point of view seems a legacy of concepts and paradigms developed during the nineteenth and twentieth centuries with the progress of microbial medicine ( 76 ). We should not remain constrained by a framework that has been very effective for microbiology but narrows our understanding of oncogenesis.…”

Glioma resection and tumor recurrence: back to Semmelweis

“…A phenomenon acquires meaning when it enters into the framework of a theory, but preexisting paradigms and theoretical commitments can also bias our observations. 9 Experimental and medical protocols may gradually become rituals. As regards glioma recurrence at the resection margin, accumulative evidence suggests that the tissue response to SBI participates in the formation of recurrence-prone microenvironments.…”

Application of a simple device for “attracting” and “trapping” glioma cells in situ

“…An ecological trap is a novel or higher quality environment, where there is a signal that misleading an animal to leave its traditional habitat. An ecological trap can drive a local population to extinction [12, 13]. However, Studies on ecological trap in cancer have largely focused on the tumor microenvironment, rather than for therapeutic purposes [14].…”